Michael L. Meyers - SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer
Stock Symbol
SNDX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael L. Meyers since 12/22/2023

Holdings reported by Michael L. Meyers for Syndax Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to buy) 17.4K $448K $25.84 Feb 2, 2022 Direct Common Stock
Common Stock 23.3K $425K $18.27 Jan 31, 2022 Direct

Transactions reported by Michael L. Meyers for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.